Cordlife Group Valuation
Is P8A undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of P8A when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: P8A (SGD0.12) is trading below our estimate of fair value (SGD0.44)
Significantly Below Fair Value: P8A is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for P8A?
Other financial metrics that can be useful for relative valuation.
What is P8A's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | S$30.76m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | n/a |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does P8A's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 14.4x | ||
1B1 HC Surgical Specialists | 9.4x | n/a | S$40.8m |
OTX Medinex | 13.7x | n/a | S$26.5m |
NPL Niks Professional | 13x | n/a | S$22.0m |
MIJ Alliance Healthcare Group | 21.4x | n/a | S$26.6m |
P8A Cordlife Group | 8.3x | n/a | S$30.8m |
Price-To-Earnings vs Peers: P8A is good value based on its Price-To-Earnings Ratio (8.3x) compared to the peer average (14.4x).
Price to Earnings Ratio vs Industry
How does P8A's PE Ratio compare vs other companies in the Asian Healthcare Industry?
Price-To-Earnings vs Industry: P8A is good value based on its Price-To-Earnings Ratio (8.3x) compared to the Asian Healthcare industry average (22.1x).
Price to Earnings Ratio vs Fair Ratio
What is P8A's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 8.3x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate P8A's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.